The Global CEO Initiative on Alzheimer’s Disease (CEOi) has unveiled an innovative Alzheimer’s Blood Test Performance ...
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the treatment of Alzheimer's disease.
A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...
The EU medicines regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's ability to slow cognitive ...
Your daily choices might protect your brain from Alzheimer's. Discover simple habits that could boost memory and keep your ...
A study published in Brain Communications revealed new insights into early detection of Alzheimer’s disease. Researchers have ...
After failing to pass muster with England’s drug reimbursement watchdog earlier this month, Eli Lilly’s Alzheimer’s disease ...
EatingWell on MSN1d
Your Dementia Risk May Be Increased by Another Disease Diagnosis—Here’s How to Prevent ItIf you’re in your 30s, 40s or 50s, dementia might feel like a distant concern, something you associate with advanced age.
Researchers at Mass General Brigham may have developed an easy and inexpensive way to detect early signs of dementia.
Eli Lilly's Kisunla was approved in the U.S. for Alzheimer's last year, but now advisers to the European Medicines Agency say it shouldn't be approved.
Olfactory tests may be a tool to identify dementia in its initial stages — when interventions are most beneficial, ...
Advocating to find a cure for Alzheimer's Disease and helping countless Arizonans in the process — that's the mission behind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback